🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06088225
Recruiting Not applicable

Myopia Preventing With Distance-image Screen

NCT06088225 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Airdoc Technology Co., Ltd.
Phase
Not applicable
Started
2022-10-01
Last updated
2023-10-24

Condition(s) studied

Myopia, Progressive

Investigational drug(s) / intervention(s)

distance-image screen

distance-image screen: Distance-image screen is a screen make each image at distance of 6-meters to reduce the accommodation and convergence for eyes during the reading and learning with screens.

Study summary

This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * (1) Must be 6\~12 years old; * (2) Must be best corrected visual acuity \< logMAR: 0.1; * (3) Spherical Equivalence (SE) must be -1.00\~ + 6.00 Diopter (D), * (4) Spherical Equivalence (SE) must have changed \> 1.25 Diopter (D) in the recent 2 years; * (5) Must be astigmatism \<1.75 Diopter (D); * (6) Must be anisometropia \<1.75 Diopter(D). Exclusion Criteria: * (1) Strabismus disease; * (2) Amblyopia disease; * (3) Cataract disease; * (4) Glaucoma disease; * (5) Severe dry eye disease; * (6) Cannot use distance-image screen for 12 month; * (7) Other severe diseases that would effect the use of distance-image screen.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Airdoc MPC Opthalmology Clinics Beijing Beijing Municipality Recruiting

More Beijing Airdoc Technology Co., Ltd. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06088225 on ClinicalTrials.gov ↗ ← All trials in China